Mandrake Bio
Mandrake Bio designs custom de novo proteins through AI and structural biology to build a more sustainable and efficient world.
Mandrake Bio designs custom de novo proteins through AI and structural biology to build a more sustainable and efficient world.
Mandrake Bio has raised $1.7M across 1 round. Its most recent round was a Pre-Seed of $1.7M in Jul 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Mandrake Bio is featured in
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.